RSS   Newsletter   Contact   Advertise with us

Perrigo announces leadership change in Rx pharmaceuticals segment

Share on Twitter Share on LinkedIn
Staff Writer | Dublin, Ireland | July 22, 2016
PerrigoJuly 22, 2016, Dublin, Ireland - Perrigo Company plc, a healthcare supplier, announced the departure of Douglas Boothe, executive vice president and general manager, Rx Pharmaceuticals.
Mr. Boothe joined Perrigo in January 2013 as Executive Vice President and General Manager, Perrigo Pharmaceuticals.

Previously, Mr. Boothe served as Chief Executive Officer of Actavis Inc. from August 2008 to December 2013 and as Executive Vice President and Chief Operating Officer from 2006 to 2008.

Prior to that position, Mr. Boothe held various senior positions in strategic planning and business development for Alpharma Inc., Pharmacia Corporation and Xerox Corporation.

John Wesolowski, Senior Vice President of Rx Commercial Operations, will assume the role of Acting General Manager, Rx pharmaceuticals.

Prior to joining Perrigo as Vice President of Commercial Operations in February 2004, Mr. Wesolowski served in several customer-facing roles at E. Fougera and Company from 1993 to 2004.


 LATEST MOVES FROM Ireland 


MORE INSIDE POST